Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  65 results for ""Receptors, Vascular Endothelial Growth Factor""

Your Filters

Geographic : united states
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Trends in Anti-Vascular Endothelial Growth Factor Original Medicare Part B Claims in the United States, 2014-2019.

  • Authors : Desai S; University of Connecticut School of Medicine, Farmington, Connecticut, USA.; Sekimitsu S

Subjects: Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/economics ; Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/therapeutic use ; Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/administration & dosage

  • Source: Ophthalmic epidemiology [Ophthalmic Epidemiol] 2024 Oct; Vol. 31 (5), pp. 468-477. Date of Electronic Publication: 2024 Feb 05.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9435674 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Anti-VEGF Pharmaceutical Prior Authorization in Retina Practices.

  • Authors : Dang S; The Retina Institute, St Louis, Missouri.; Parke DW

Subjects: Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/therapeutic use ; Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/administration & dosage ; Vascular Endothelial Growth Factor A*/Vascular Endothelial Growth Factor A*/Vascular Endothelial Growth Factor A*/antagonists & inhibitors

  • Source: JAMA ophthalmology [JAMA Ophthalmol] 2024 Aug 01; Vol. 142 (8), pp. 716-721.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print

Record details

Read More Add to Saved list
×
Academic Journal

Cost-effectiveness of ranibizumab and aflibercept to treat diabetic macular edema from a US perspective: analysis of 2-year Protocol T data.

Subjects: Angiogenesis Inhibitors/Angiogenesis Inhibitors/Angiogenesis Inhibitors/*therapeutic use ; Diabetes Complications/Diabetes Complications/Diabetes Complications/*drug therapy ; Macular Edema/Macular Edema/Macular Edema/*drug therapy

  • Source: Journal of medical economics [J Med Econ] 2020 Mar; Vol. 23 (3), pp. 287-296. Date of Electronic Publication: 2019 Nov 04.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Thyroid dysfunction related to vascular endothelial growth factor receptor tyrosine kinase inhibitors: A real-world study based on FAERS.

  • Authors : Liao X; College of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, China.; Department of Pharmacy, 900 Hospital of the Joint Logistics Team, Fuzhou, China.

Subjects: Adverse Drug Reaction Reporting Systems/Adverse Drug Reaction Reporting Systems/Adverse Drug Reaction Reporting Systems/*statistics & numerical data ; Protein Kinase Inhibitors/Protein Kinase Inhibitors/Protein Kinase Inhibitors/*adverse effects ; Receptors, Vascular Endothelial Growth Factor/Receptors, Vascular Endothelial Growth Factor/Receptors, Vascular Endothelial Growth Factor/*antagonists & inhibitors

  • Source: Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2021 Oct; Vol. 46 (5), pp. 1418-1425. Date of Electronic Publication: 2021 Jun 24.Publisher: Country of Publication: England NLM ID: 8704308 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2710

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Comparative Effectiveness Trial for Diabetic Macular Edema: Three Comparisons for the Price of 1 Study From the Diabetic Retinopathy Clinical Research Network.

  • Authors : Jampol LM; Feinberg School of Medicine, Northwestern University, Chicago, Illinois.; Glassman AR

Subjects: Angiogenesis Inhibitors/Angiogenesis Inhibitors/Angiogenesis Inhibitors/*therapeutic use ; Bevacizumab/Bevacizumab/Bevacizumab/*therapeutic use ; Diabetic Retinopathy/Diabetic Retinopathy/Diabetic Retinopathy/*drug therapy

  • Source: JAMA ophthalmology [JAMA Ophthalmol] 2015 Sep; Vol. 133 (9), pp. 983-4.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print

Record details

Read More Add to Saved list
×
Academic Journal

Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA.

Subjects: Angiogenesis Inhibitors/Angiogenesis Inhibitors/Angiogenesis Inhibitors/*therapeutic use ; Macular Degeneration/Macular Degeneration/Macular Degeneration/*drug therapy ; Ranibizumab/Ranibizumab/Ranibizumab/*therapeutic use

  • Source: PloS one [PLoS One] 2015 Jul 24; Vol. 10 (7), pp. e0133968. Date of Electronic Publication: 2015 Jul 24 (Print Publication: 2015).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Predictors of sustained intraocular pressure elevation in eyes receiving intravitreal anti-vascular endothelial growth factor therapy.

  • Authors : Yannuzzi NA; Weill Cornell Medical College, New York, New York; LuEsther T. Mertz Retinal Research Center, Manhattan Eye, Ear, and Throat Hospital, New York, New York.

Subjects: Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*administration & dosage ; Intraocular Pressure/Intraocular Pressure/Intraocular Pressure/*drug effects ; Macular Degeneration/Macular Degeneration/Macular Degeneration/*drug therapy

  • Source: American journal of ophthalmology [Am J Ophthalmol] 2014 Aug; Vol. 158 (2), pp. 319-327.e2. Date of Electronic Publication: 2014 May 06.Publisher: Elsevier Science Country of Publication: United States NLM ID: 0370500 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

The Association of Angiogenesis Markers With Acute Kidney Injury and Mortality After Cardiac Surgery.

Subjects: Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/blood ; Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/diagnosis ; Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/etiology

  • Source: American journal of kidney diseases : the official journal of the National Kidney Foundation [Am J Kidney Dis] 2019 Jul; Vol. 74 (1), pp. 36-46. Date of Electronic Publication: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 8110075 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

A Multinational Comparison of Anti-Vascular Endothelial Growth Factor Use: The United States, the United Kingdom, and Asia-Pacific.

  • Authors : Parikh R; Vitreous, Retina, and Macula Consultants of New York, New York, New York; LuEsther Mertz Retinal Research Center, New York, New York

Subjects: Drug Costs/Drug Costs/Drug Costs/*statistics & numerical data ; Public Health/Public Health/Public Health/*economics ; Ranibizumab/Ranibizumab/Ranibizumab/*administration & dosage

  • Source: Ophthalmology. Retina [Ophthalmol Retina] 2019 Jan; Vol. 3 (1), pp. 16-26. Date of Electronic Publication: 2018 Aug 09.Publisher: Published by Elsevier Inc. on behalf of American Academy of Ophthalmology Country of Publication: United States NLM ID:

Record details

Read More Add to Saved list
×
Academic Journal

Retrospective analysis of first-line anti-vascular endothelial growth factor treatment patterns in wet age-related macular degeneration.

  • Authors : Johnston SS; Truven Health Analytics, 7700 Old Georgetown Rd, Ste 650, Bethesda, MD, 20814, USA, .; Wilson K

Subjects: Health Care Costs*; Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*administration & dosage ; Receptors, Vascular Endothelial Growth Factor/Receptors, Vascular Endothelial Growth Factor/Receptors, Vascular Endothelial Growth Factor/*administration & dosage

  • Source: Advances in therapy [Adv Ther] 2013 Dec; Vol. 30 (12), pp. 1111-27. Date of Electronic Publication: 2013 Dec 06.Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
  • 1-10 of  65 results for ""Receptors, Vascular Endothelial Growth Factor""